What is it about?
Cancer is a leading cause of death worldwide. Traditional cancer therapies such as chemotherapy and radiotherapy have several limitations, such as targeted drug delivery, toxicity to healthy cells, damage to nearby tissues, and resistance against chemotherapeutics. Nanoparticles have the potential to overcome these limitations. Nanoparticles can be modified in such a way that they can redirect to the cancer cells and kill them selectively without destroying the healthy cells. They can also be used to encapsulate the chemotherapeutic drugs and selectively release the drug in the target cells. Nowadays, they are used for image-guided photothermal cancer therapies.
Photo by National Cancer Institute on Unsplash
Why is it important?
Traditional cancer therapies have several limitations and side effects. Nanoparticles can be used to overcome the existing limitations regarding cancer therapy.
Read the Original
This page is a summary of: Surface-functionalised hybrid nanoparticles for targeted treatment of cancer, IET Nanobiotechnology, September 2020, the Institution of Engineering and Technology (the IET),
You can read the full text:
The following have contributed to this page